1. Home
  2. SRPT vs MMS Comparison

SRPT vs MMS Comparison

Compare SRPT & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • MMS
  • Stock Information
  • Founded
  • SRPT 1980
  • MMS 1975
  • Country
  • SRPT United States
  • MMS United States
  • Employees
  • SRPT N/A
  • MMS N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • MMS Business Services
  • Sector
  • SRPT Health Care
  • MMS Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • MMS Nasdaq
  • Market Cap
  • SRPT 1.7B
  • MMS 3.9B
  • IPO Year
  • SRPT 1997
  • MMS 1997
  • Fundamental
  • Price
  • SRPT $18.19
  • MMS $72.06
  • Analyst Decision
  • SRPT Buy
  • MMS Buy
  • Analyst Count
  • SRPT 25
  • MMS 1
  • Target Price
  • SRPT $64.00
  • MMS $90.00
  • AVG Volume (30 Days)
  • SRPT 7.9M
  • MMS 412.7K
  • Earning Date
  • SRPT 08-06-2025
  • MMS 08-06-2025
  • Dividend Yield
  • SRPT N/A
  • MMS 1.67%
  • EPS Growth
  • SRPT N/A
  • MMS 31.21
  • EPS
  • SRPT N/A
  • MMS 5.00
  • Revenue
  • SRPT $2,233,371,000.00
  • MMS $5,395,260,000.00
  • Revenue This Year
  • SRPT $26.87
  • MMS $2.13
  • Revenue Next Year
  • SRPT $3.15
  • MMS $3.36
  • P/E Ratio
  • SRPT N/A
  • MMS $14.42
  • Revenue Growth
  • SRPT 59.15
  • MMS 5.29
  • 52 Week Low
  • SRPT $16.88
  • MMS $63.77
  • 52 Week High
  • SRPT $155.95
  • MMS $93.97
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 23.09
  • MMS 55.70
  • Support Level
  • SRPT $16.88
  • MMS $69.43
  • Resistance Level
  • SRPT $18.62
  • MMS $70.39
  • Average True Range (ATR)
  • SRPT 1.40
  • MMS 1.58
  • MACD
  • SRPT 0.09
  • MMS 0.34
  • Stochastic Oscillator
  • SRPT 6.41
  • MMS 86.15

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: